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Erythrokeratodermia variabilis is an autosomal domi-
nant genodermatosis characterized by persistent
plaque-like or generalized hyperkeratosis and transient
red patches of variable size, shape, and location. The
disorder maps to a cluster of connexin genes on chro-
mosome 1p34^p35.1 and, in a subset of families, results
from mutations in the gene GJB3 encoding the gap
junction protein connexin-31 (Cx31). A recent report
suggested the involvement of another connexin gene
(GJB4) in the etiology of erythrokeratodermia variabi-
lis. In this study, we sequenced the coding region of
GJB4 in 13 unrelated erythrokeratodermia variabilis fa-
milies without detectable mutations in GJB3. Mutation
analysis revealed six distinct missense mutations in ¢ve
families and a sporadic case of erythrokeratodermia
variabilis, all of which were not found in controls. Mu-
tation G12D, identi¢ed in an extended Dutch family,
lies in the predicted amino-terminus and may interfere
with the £exibility of this domain, connexin selectivity,
or gating polarity of gap junction channels. Other mu-
tations (R22H,T85P, F137L, F189Y) were located in the
transmembrane domains of Cx30.3, and are predicted
to hinder regulation of voltage gating or alter the ki-
netics of channel closure. A¡ected individuals of two
unrelated families harbored point mutations leading to
amino acid substitution F137L, which was also reported
in GJB3, yet the extent and severity of hyperkeratosis
was milder compared to the corresponding mutation
in GJB3. Two mutations (T85P, F137L) were associated
with the occurrence of rapidly changing erythematous
patches with prominent, circinate, or gyrate borders in
a¡ected children but not in adults, supporting the no-
tion that this feature is speci¢c to Cx30.3 defects. Never-
theless, we observed highly variable intrafamilial
phenotypes, suggesting the strong in£uence of modify-
ing genetic and epigenetic factors. In addition to patho-
genic mutations, we identi¢ed several missense
mutations and a 4 bp deletion within the GJB4 coding
region, which might represent either inconsequential
polymorphisms or recessive mutations. In conclusion,
our results demonstrate genetic heterogeneity in ery-
throkeratodermia variabilis, and emphasize that inter-
cellular communication mediated by both Cx31 and
Cx30.3 is crucial for epidermal di¡erentiation. Key
words: connexin/epidermal di¡erentiation/erythrokeratodermia
variabilis/gap junction communication/mutation. J Invest
Dermatol 120:601 ^609, 2003
I
n1925, Dutch dermatologist Mendes da Costa described the
striking clinical features of a genodermatosis, which he
named ‘‘erythro- et keratodermia variabilis’’ (EKV; MIM
133200) (Mendes da Costa, 1925). As re£ected by this name,
EKV is characterized by the presence of hyperkeratosis and
extraordinarily variable areas of transient erythema that may co-
exist or occur independently. Some patients develop relatively
¢xed, yellow- or red-brown, hyperkeratotic plaques with well-
demarcated, geographic borders that are symmetrically distribu-
ted over the extensor surface of extremities, buttocks, and lateral
trunk. In others, hyperkeratosis is persistently severe and wide-
spread, with accentuated skin markings, ¢ne attached scaling,
and, rarely, ichthyosis hystrix-like appearance. Patchy or di¡use
palmoplantar keratoderma (PPK) is common (450%), and areas
of super¢cial peeling or hypertrichosis are not unusual (Richard,
2001). The hallmark of EKV is the continual occurrence of
transient, sharply outlined, ¢gurate red patches of variable
intensity that fade within a few hours or days. The erythema
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is often triggered by sudden temperature changes or
emotional stress, whereas hyperkeratosis may be provoked
by chronic mechanical irritation of the skin (Richard,
2001).
EKV is inherited as an autosomal dominant trait and has been
mapped in several extended families to a single genetic locus
on human chromosome 1p34p35.1 (van der Schroe¡ et al, 1984;
Richard et al, 1997; Macari et al, 2000). The 2.6 cM candidate gene
region was found to harbor four connexin (Cx) genes encoding
the gap junction proteins Cx30.3 (GJB4), Cx31 (GJB3), Cx31.1
(GJB5), and Cx37 (GJA4) (Richard et al, 1997; Macari et al, 2000),
which cluster within less than 40 kb. In 1998, Richard et al iden-
ti¢ed the GJB3 gene and detected pathogenic missense mutations
in four families with EKV, linking for the ¢rst time a defect in
the cutaneous gap junction system to disturbed epidermal di¡er-
entiation and function (Richard et al, 1998a). To date, a total of six
distinct dominant GJB3 mutations have been identi¢ed in eight
unrelated EKV families (Wilgoss et al, 1999; Richard et al, 2000).
All nucleotide changes lead to heterozygous amino acid substitu-
tions, four of which (G12D, G12R, R42P, and C86S) were shown
to alter gap junction communication and/or induce cell death
in vitro (Di et al, 2002; Diestel et al, 2002; Rouan et al, in press). In
addition, evidence emerged for an autosomal recessive variant
of EKV caused by the homozygous missense mutation L34P
(Gottfried et al, 2002). Nevertheless, as more than half of all tested
EKV families did not harbor GJB3 mutations, it was proposed
that EKV might be genetically heterogeneous (Richard et al,
2000). This hypothesis was supported by genetic studies in a large
Israeli-Kurdish EKV family, which revealed a heterozygous mis-
sense mutation (F137L) in the gene GJB4 encoding Cx30.3, thus
implicating yet another connexin gene in the pathogenesis of
EKV (Macari et al, 2000).
Both Cx31 and Cx30.3 appear to be preferentially expressed in
the upper di¡erentiating layers of rodent and human epidermis
and build with at least six other connexin constituents a complex
and redundant gap junction network (Macari et al, 2000; Di et al,
2001; Richard, 2001). Gap junctions, which can be found in all
tissues of the human body, are arrays of aqueous intercellular
channels connecting neighboring cells. They allow direct
cellcell communication by rapid transfer of physiologic signals,
ions, and small nutrients, which is pivotal for the coordination
and synchronization of cellular responses to internal and external
stimuli (Bruzzone et al, 1996). Gap junction channels are formed
by connexins, a multigene family of at least 20 distinct integral
membrane proteins in human (Willecke et al, 2002). Connexin
monomers oligomerize to hexameric hemichannels (connexons),
which accumulate at the plasma membrane where they dock
head-to-head with connexons of apposing cells to complete a
channel. As most tissues express several connexins, channels can
be composed of connexons of the same type (homotypic), di¡er-
ent types (heterotypic), or from mixed connexons (heteromeric)
depending on their compatibility code, each with di¡erent chan-
nel permeability and gating properties. Each subunit is predicted
to form four membrane-spanning a-helices (M1M4) that may
participate in forming the channel walls. Two extracellular do-
mains (E1, E2) extend about 2 nm into the extracellular space,
where they connect with their counterparts. Together with the
cytoplasmic amino-terminus (NT), these domains are highly
conserved among connexins, whereas the cytoplasmic central
loop (CL) and carboxy-terminus are more variable and are as-
sumed to determine connexin-speci¢c attributes (Bruzzone et al,
1996).
The importance of gap junction intercellular communication
for skin function and in particular epidermal di¡erentiation is re-
£ected by the large number of hereditary skin disorders that are
caused by connexin gene mutations, including EKV, PPK asso-
ciated with hearing loss, hidrotic ectodermal dysplasia (Clouston
syndrome) (for review see Richard, 2001), and KID syndrome
(Richard et al, 2002; van Steensel et al, 2002). To further explore
the causal role of Cx30.3 gene defects in the pathogenesis of EKV
and to elucidate genotypephenotype correlations, we studied 13
unrelated EKV families that did not harbor detectable mutations
in the Cx31 gene GJB3.
MATERIALS ANDMETHODS
Patients and biologic material We studied 57 patients a¡ected with
EKV from 13 unrelated families with their informed consent (108
individuals in total). Our cohort comprised ¢ve multigeneration families
demonstrating linkage to the 1p locus (EKV15) (Richard et al, 1997;
S. Morley, personal communication), four nuclear families (EKV69),
and four sporadic cases (EKV1013). With the exception of an African-
American child, other patients were of northern and central European
origin. The clinical diagnosis of EKV was established in at least one
a¡ected individual in each family by medical history, dermatologic
examination performed by at least two dermatologists, and histo-
pathologic evaluation of a skin biopsy. DNA samples from all partici-
pating individuals were obtained either from venous blood samples using
standard extraction procedures or from buccal mucosa cells (Richards et al,
1993).
DNA ampli¢cation and mutation analysis The genomic sequence
of GJB4 was obtained from the published sequence of human clone
RP1^34M23 assigned to chromosome 1p34.3^36.11 (GenBank accession
number AL121988.10), which contains a contiguous cluster of four
connexin genes including GJA4, GJB3, GJB4, and GJB5. The genomic
organization of GJB4 is similar to other connexin genes, including a ¢rst
untranslated exon and a second exon that contains the entire coding
information, separated by a single intron. For mutation analysis, using
polymerase chain reaction (PCR) we ampli¢ed exon 2 and £anking
untranslated regions in a 965 bp fragment using primers (1þ)
50 -TCAATCGCACCAGCATTAAG-30 and (2) 50 -GGGGGACCTGTT
GATCTTATC-30 derived from the genomic sequence. PCR ampli¢cation
was performed from genomic DNA using Taq DNA polymerase (Qiagen,
Valencia, CA) and standard PCR conditions (941C for 2 min; 36 cycles of
941C for 30 s, 601C for 50 s, 721C for 1 min; and ¢nally 721C for 7 min).
Amplicons were gel puri¢ed (QIAquick gel extraction kit, Qiagen) and
directly sequenced using the BigDye terminator sequencing system on an
ABI Prism 377 sequencer (PE Applied Biosystems, Foster City, CA).
Sequence variants were con¢rmed by bidirectional DNA sequencing. In
addition, we used restriction fragment analysis or denaturing high
performance liquid chromatography (dHPLC) to verify the segregation of
each mutation in the family of the proband and to exclude mutations from
at least 184 population-matched control chromosomes. For restriction
enzyme digestion with FauI, MseI, and Tsp45I we generated 587 bp
amplicons, whereas 281 bp fragments were ampli¢ed for digestion with
AvaII (primers available upon request). Amplicons were puri¢ed with
MicroSpint S-400 columns (Amersham Pharmacia Biotech, Piscataway,
NJ), digested for 2 h according to the supplier’s recommended conditions
(New England Biolabs, Beverly, MA), and analyzed on 6% nondenaturing
TBE gels (Novex, San Diego, CA). For dHPLC analysis, we PCR-
ampli¢ed GJB4 in two overlapping fragments with primers (1þ) and
(3) 50 -TTGTAGAGGCGGTGGAAGAT-30 and (5þ ) 50 -CCTGTACGA
CAACCTGAGCA-30 and (2), mixed each sample with a control sample
in a ratio of 2 :1 (vol/vol), denatured at 941C for 10 min, cooled to 651C
for 10 min to allow heteroduplex formation, and maintained samples
on ice until loading. Ten microliters of each sample were separately
injected and analyzed on a WAVEt DNA fragment analysis system
(Transgenomic, Omaha, NE), over 7.5 min at temperature gradients of
621C and 641C that were established with theWAVE Maker program 3.4
(Transgenomic).
Electronic database information Online Mendelian Inheritance of
Man (OMIM), http://www3.ncbi.nlm.nih.gov/Omim/searchomim.html;
The Connexin-Deafness Homepage, http://www.iro.es/deafness/; The
Human Gene Mutation Database, http://archive.uwcm.ac.uk/uwcm/mg/
hgmd0.html; GenBank, http://www.ncbi.nlm.nih.gov/GenBank/Gen
BankSearch.html (for accession numbers AL121988 [GJB4]; Q9NTQ9
[hCx30.3]).
RESULTS
GJB4 mutations and their corresponding phenotypes We
studied the clinical characteristics of EKV in nine families
(EKV19) and four sporadic cases (EKV1013) (Table I) and
searched for disease-causing mutations in the coding sequence of
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GJB4. Each family presented with characteristic skin ¢ndings of
EKV. The hyperkeratosis was con¢ned to localized plaques in 10
families, and individuals of the remaining three families had
more widespread involvement. In three families, patchy or
di¡use, glove-like PPKwas observed. Mutation analysis revealed
six distinct heterozygous missense mutations (Tables II, III;
Fig 5), each of them completely cosegregating with the disease
phenotype but not being detectable in a panel of at least 92
unrelated Caucasian control individuals.
Family EKV1 Members of this family were descendants of an
extended Dutch pedigree, which could be traced to a common
ancestor seven generations ago, and was originally used to map
EKV near the Rh blood group locus on 1p (van der Schroe¡ et
al, 1984). All ¢ve a¡ected individuals from three di¡erent
branches of this family carried a heterozygous G-to-A transition
at nucleotide 35 (from ATG start site) in codon 12, changing
glycine (GGC) to a negatively charged aspartic acid (GAC)
(Fig 1A). This substitution a¡ects a residue in the cytoplasmic
NT domain of Cx30.3 that is highly conserved among all
members of the b-connexin family across species, and can be
expected to seriously compromise conformation and functional
properties of Cx30.3. The mutation introduces a new
recognition sequence for Tsp45I and thus alters the pattern of
PCR amplicons of GJB4 upon digestion (Fig 1A). Clinically, all
individuals harboring mutation G12D showed typical features of
EKV with extensive, symmetric, well-demarcated hyperkeratotic
plaques on extremities and trunk and independently occurring,
short-lasting erythematous patches (Fig 1B) without striking
phenotypic di¡erences.
Family EKV2 This family was composed of 30 members, 16 of
whom were a¡ected and harbored an A-for-C substitution at
nucleotide 253 (Fig 2A). This mutation replaced the conserved
threonine 85 (ACG) residue with proline (CCG) and created a
new AvaII cut site used for restriction fragment analysis, which
con¢rmed the cosegregation of T85P with the EKV phenotype
(Fig 2A). Structural predictions suggested that mutation T85P
falls within the second transmembrane region M2, which is
thought to contribute to the lining of the channel pore and
regulation of voltage gating (Veenstra, 1996). The clinical
presentation of EKV was highly variable within this family,
but most individuals showed at examination relatively ¢xed
hyperkeratotic plaques (see below).
Family EKV3 In this family, we detected aT-to-A substitution
at nucleotide 566 leading to a nonconservative change of
phenylalanine 189 (TTC) to tyrosine (TAC), which was
con¢rmed by dHPLC analysis (Fig 3A). Mutation F189Y
eliminates another conserved phenylalanine residue in the fourth
membrane domain of Cx30.3, which might potentially interfere
with connexon assembly (Bruzzone et al, 1996). In contrast to
other families, the prevailing feature in EKV3 was severe
hyperkeratosis with accentuated skin markings, ridging in large
skin folds, and noticeable hypertrichosis lanuginosa (Fig 3B),
but sparing palms, soles, and scalp.
Family EKV4 In this family, dHPLC and mutation analysis
revealed a T-to-C transition of nucleotide 409 (Fig 4A). The
mutation, which has been previously observed in another EKV
family (Macari et al, 2000), is predicted to replace a strictly
conserved phenylalanine residue 137 (TTC) in the third
transmembrane domain of Cx30.3 with leucine (CTC). This
amino acid substitution could potentially alter topogenic
assembly of connexons or kinetics of channel closure (Macari
et al, 2000). In all a¡ected individuals, we noted localized
hyperkeratotic plaques with foci of super¢cial peeling and red
patches mostly con¢ned to the hyperkeratotic areas (Fig 4BD).
Table I. Clinical features of patients with EKVanalyzed for GJB4 mutationsa
ID Linked to
1p35
Generalized
hyperkeratosis
Localized
hyperkeratosis
PPK Variable, transient
erythema
Other features GJB4 mutation
EKV1 þ þ þ G12D
EKV2 þ þ þ þ Circinate or targetoid erythema T85P
EKV3 þ þ þ Hyperpigmentation, hypertrichosis F189Y
EKV4 þ þ þ þ Peeling; hypertrichosis F137L
EKV5 þ þ þ ^
EKV6 þ þ Hypertrichosis ^
EKV7 þ þ ^
EKV8 þ þ þ CIE-likeb ¢ne, white scaling ^
EKV9 þ þ Peeling R22H
EKV10 þ þ þ þ þ Hypopigmentation, hypertrichosis ^
EKV11 þ þ Circinate, gyrate erythema F137L
EKV12 þ þ Peeling; hypertrichosis ^
EKV13 þ þ ^
aWithout mutations in the coding sequence of GJB3 (Cx31).
bCIE, congenital ichthyosiform erythroderma.
Table II. GJB4 mutations identi¢ed in six families with EKV
Family ID Nucleotide change Codon Connexin domain Con¢rmation
EKV01 35 G/A G12D NT Tsp45I
EKV02 253 A/C T85P M2 AvaII
EKV09 64 G/A R22H M1 dHPLC
EKV04 409 T/C F137L M3 dHPLC
EKV11 411 C/A F137L M3 MseI
EKV03 566 T/A F189Y M4 dHPLC
Table III. GJB3 and GJB4 mutations previously
identi¢ed in EKV
Gene Nucleotide
change
Codon Connexin
domain
Con¢rmation Reference
GJB4 411C/A F137L M3 Tsp45I Macari et al (2000)
GJB3 34G/C G12R NT BsrB1 Richard et al (1998)
GJB3 35G/A G12D NT BsrB1 Richard et al (1998)
GJB3 34G/A G12S NT BsrB1 Richard (2001)
GJB3 101T/C L34Pa M1 BanI Gottfried et al (2002)
GJB3 125G/C R42P M1/E1 BstUI Richard et al (2000)
GJB3 125G/C R42P M1/E1 HinP1I Wilgoss et al (1999)
GJB3 256T/A C86S M2 NlaIII Richard et al (1998)
GJB3 256T/A C86S M2 NlaIII Richard et al (1998)
GJB3 409T/C F137L M3 MboII Richard et al (2000)
aRecessive mutation.
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Family EKV9 Both a¡ected individuals EKV9-1 and EKV9-3
carried a heterozygous G-to-A substitution replacing arginine 22
(CGC) with histidine (CAC) in the ¢rst transmembrane domain
of Cx30.3. This mutation R22H was not present in una¡ected
family members or in unrelated controls as determined by
dHPLC analysis (Fig 1C). The clinical features included
symmetric hyperkeratotic plaques on the extremities without
PPK and faint underlying erythema as well as transient red
patches. The a¡ected parent EKV9-1 noticed a marked age-
related regression of both morphologic components.
Family EKV11 The a¡ected child EKV11-3 in this family
harbored a C-to-A transversion of nucleotide 411, thus resulting
in amino acid substitution F137L, similar to family EKV4. This
mutation, which generates a new MseI cut site, was not detected
in DNA samples of either una¡ected parent, suggesting that it
has arisen de novo in this patient or re£ects germline mosaicism
(Fig 4E). Initially, the proband had well-de¢ned, hyperkeratotic
plaques symmetrically distributed over the lower extremities and
buttocks (Fig 4F). The hyperkeratosis progressively worsened
resulting in generalized involvement at the age of 5 y. From 3
mo of age, autonomous erythematous patches with prominent,
raised, circinate borders and rapidly changing con¢guration were
noted, leading to a garland-like appearance (Fig 4F, G).
In the remaining seven EKV families, one of which links to
the connexin cluster on 1p (S. Morley, personal communication),
we were unable to detect pathogenic mutations in GJB3 or GJB4
and the molecular cause of EKV in these families still remains
elusive. A retrospective critical evaluation of their clinical
phenotype revealed that none of the patients had circinate or
gyrate erythema as seen in several families segregating GJB4
mutations. Considerable interfamilial phenotypic variability, as
illustrated for families with GJB4 mutations above, was also
observed within this subgroup of seven families complicating
direct clinical comparisons (see Table I). Nevertheless, we did
not observe any discriminatory or consistently deviant clinical
features of EKV that would allow us to clinically di¡erentiate
these patients from others harboring mutations in GJB4 or
GJB3.
Variable intrafamilial expressivity of GJB4 mutations In
family EKV2, clinical studies of 16 individuals with EKV from
three generations carrying mutation T85P revealed marked
intrafamilial variability of clinical features and striking age-
dependent di¡erences. Of the a¡ected individuals, ¢ve adults
between 23 and 70 y of age had no erythematous component
at the time of examination (Fig 2C) but all had a history
of ‘‘blotching’’ and recurring red patches during childhood. In
Figure1. Mutations G12D in EKV1 and R22H in EKV9. (A) Sequence analysis reveals a G-to-A transition that substitutes glycine 12 with aspartic acid
(top left panel) compared to the normal sequence (bottom left panel). Restriction fragment analysis withTsp45I (lower right panel) con¢rms cosegregation of this
mutation with the EKV in the family (upper right panel). The mutation introduces a new cut site, resulting in additional DNA bands of 159 bp and 51 bp (not
shown) in a¡ected individuals. M, 100 bp marker; U, undigested control; lane numbers correspond to individuals in the pedigree. (B) Variable erythematous
patches within well-demarcated, symmetrically distributed hyperkeratotic plaques on the frontal trunk of individual EKV1-5. (C) Pedigree of EKV9 (middle
panel) and sequence panels (top left) showing the G-to-A transition replacing arginine 22 with histidine and the normal sequence (bottom left). dHPLC
analysis demonstrates an additional peak in the melting curve (EKV9-3) due to heteroduplex formation in the presence of the mutation (top right) compared
to a control sample (bottom right).
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contrast, ¢ve out of 11 children and adolescents aged 2^16 y
showed widely distributed, rapidly changing erythematous
patches. In four of them, the erythema had well-de¢ned,
circinate borders and assumed annular, targetoid, or garland-like
shapes (Fig 2B, E). Extent and localization of hyperkeratosis
di¡ered from person to person and during the course of disease.
In most a¡ected individuals (10 of 16), hyperkeratosis was limited
to a few plaques over large joints (Fig 2C), whereas four others
had larger plaques on extremities and trunk and mild PPK,
covering425% of the body surface. Finally, one individual
(EKV2-2) had neither hyperkeratosis nor erythema when
examined at 60 and 62 y of age. She carried mutation T85P,
had an a¡ected child (EKV2-9), and was reported to
have irregular red spots on exposed skin areas during the
winter season. Indeed, well-demarcated, erythematous patches
with irregular outline could be experimentally provoked
when she spent 15 min in a cold room at 41C (Fig 2D),
although limited local cold exposure (ice cube test) did not
elicit an abnormal skin reaction. Collectively, these observations
in family EKV2 illustrate intrafamilial clinical heterogeneity
and reduced expressivity of the T85P mutation and underscore
that the phenotypic expression of a dominant connexin
mutation may critically depend on the individual’s genetic
background and other epigenetic (e.g., age, stress, climate)
factors.
Identi¢cation of common sequence variants in GJB4 In
addition to the pathogenic mutations delineated above, we
identi¢ed a series of sequence variants that did not cosegregate
with EKV or were only found in the control cohort (Table IV).
The silent sequence variant 369G/A (K123K) was found in one
a¡ected member of EKV3, whereas an una¡ected member of
the same family carried the heterozygous nucleotide substitution
611A/C resulting in nonconservative replacement of glutamic
acid 204 with alanine (E204A). Glu204 is a charged residue at
the boundary between the fourth transmembrane domain and
the cytoplasmic carboxy-terminus tail domain, invariably
present at this position in connexins of di¡erent species. Other
missense mutations solely detected in una¡ected controls in a
heterozygous state included R124Q and C169W. Whereas the
former amino acid substitution falls within the highly variable
cytoplasmic loop, cysteine 169 is one of three highly conserved
cysteines in the second extracellular loop that stabilize connexon
structure by forming intramolecular disul¢de bonds (Foote
et al, 1998). Most interestingly, we identi¢ed in six out of 92
control individuals a heterozygous 4 bp deletion starting from
nucleotide 154 on one allele of GJB4 (Fig 5A). This deletion,
which could be easily detected by HPLC analysis under
nondenaturing conditions (Fig 5B), leads to frameshift and
introduces a premature termination codon 54 residues
downstream of the mutation site. The transcript containing
the premature termination codon may be rapidly degraded
through nonsense mediated RNA decay (Frischmeyer and
Dietz, 1999), and the deletion may generate in essence a null
allele. Despite these predictions, the 4 bp deletion was the most
common sequence variant of Cx30.3 seen heterozygously in
Figure 2. MutationT85P in EKV2. (A) The sequence chromatogram of a¡ected individual EKV2-5 depicts a heterozygous A-to-C transversion leading
to missense mutationT85P in comparison to a control (top panel). This mutation creates a new recognition site forAvaII and results in two additional DNA
bands of 210 bp and 71 bp (not shown) in a¡ected individuals (lower panel). The lane ID numbers correspond to individual ID numbers in the pedigree of
EKV2 (middle panel). M, 100 bp marker; C, control. (B) Extensive hyperkeratotic plaques on the frontal trunk and arms of an 8-y-old boy (EKV2-30). Note
the target-like (-) and circinate (5) erythematous patches indicated by arrows. (C) Fixed, hyperkeratotic plaques over both knees without erythema in
individual EKV2-13. (D) Preauricular, sharply demarcated erythematous patch occurring during 15 min cold exposure of individual EKV2-2. (E) Close-
up of erythematous patches with circinate borders in individual EKV2-30.
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3.3% of all tested individuals, and not associated with a cutaneous
phenotype.
DISCUSSION
We report here six distinct point mutations in the Cx30.3 gene
GJB4, ¢ve of which have not been reported before, in ¢ve fa-
milies and a sporadic case of EKV. Our results ¢rmly establish
the causal role of GJB4 mutations in EKV and demonstrate that
this rare disorder of corni¢cation is genetically heterogeneous and
can result from mutations in the two closely related epidermal
connexin genes GJB3 and GJB4. A comparison of the nature
and location of mutations a¡ecting Cx31 and Cx30.3 reveals
striking similarities. All autosomal dominant point mutations
lead to nonconservative amino acid substitutions, which appar-
ently cluster (i) at Gly12 in the cytoplasmic NT domain, and (ii)
in the membrane-spanning a-helices (Fig 6). Gly12 lies within
a conserved window of six residues. It is shared between all
b-type connexins, and it is one of four discriminatory residues
that fundamentally di¡er in their chemical and physical pro-
perties between the a- and b-connexins (M. Falk, personal
communication).
To date, pathogenic mutations involving residues 11 and 12
have been reported in no less than ¢ve di¡erent b-connexin
genes, giving rise to CharcotMarieTooth disease (G12S and
S11G in Cx32), Clouston syndrome (G11S in Cx30), KID syn-
drome (G12D in Cx26), and EKV (G12D, G12R in Cx31, and
G12D in Cx30.3) (Bergo¡en et al, 1993; Richard et al, 1998a;
2002; Lamartine et al, 2000). This clustering of mutations points
to a speci¢c function for the nonpolar glycine at this position. Its
replacement with a highly polar residue signi¢cantly changes the
net charge of the NT tail, which is a crucial part of the transjunc-
tional voltage sensor of gap junction channels, and may thus
greatly alter ion permeation (Verselis et al, 1994; Purnick et al,
2000a; 2000b). In addition, Gly12 seems to determine conforma-
tion and £exibility of the NT. Nuclear magnetic resonance ana-
lysis of a synthetic peptide corresponding to the NT of Cx26
revealed the presence of a £exible hinge (open turn) initiated by
Gly12, which is thought to permit the placement of the distal end
of the NT into the channel pore (Purnick et al, 2000a). Substitu-
tion of Gly12 with residues predicted to decrease £exibility at this
area (G12S, G12Y, G12V) completely compromised the function
of Cx32 channels, whereas substitution with proline (G12P) had
no signi¢cant e¡ect (Purnick et al, 2000a). Moreover, there is evi-
dence that a sequence motif in the NT is involved in determining
the connexin selectivity and hetero-oligomerization (Falk et al,
1997). It is likely that Gly12 mutations of Cx30.3 and Cx31 in
EKV interfere with one or more of these mechanisms and thus
alter connexin function and/or gap junction communication in
the epidermis.
Insight into mutation-speci¢c di¡erences of functional impli-
cations have also emerged from in vitro studies in HeLa cells ex-
pressing the Cx31 mutants G12D and G12R. Whereas both
mutant variants of Cx31 formed normal-appearing gap junctional
plaques at points of cellcell contacts, dye transfer and calcium
monitoring experiments demonstrated that G12D-Cx31 channels
were nonfunctional (loss of function) (Rouan et al, in press). In
contrast, G12R-Cx31 resulted in a signi¢cant increase of intercel-
lular dye coupling (gain of function) possibly due to defective
closure of gap junction channels and subsequent cell death (Dies-
tel et al, 2002). Another study in NEB1 keratinocytes revealed
evidence for impaired intracellular tra⁄cking of Cx31 mutants
(Di et al, 2002). Collectively, these observations suggest that any
deviation from normal connexin and gap junction function can
have detrimental consequences for intercellular communication
and survival of epithelial cells.
All other mutations resulting in an EKV phenotype, several of
which were observed in more than one family (R42P, C86S,
F137L), are localized in the phylogenetically conserved transmem-
brane domains of Cx31 and Cx30.3 (Fig 6). These a-helical
segments anchor the protein in the plasma membrane and contri-
bute to the wall of the channel pore, regulating voltage gating
and channel closure. Many dominant connexin mutations
Figure 3. Mutation F189Y in EKV3A. Compared to the wild-type allele, sequence analysis demonstrates a heterozygousT-to-A transversion resulting in
missense mutation F189Y (top panel). dHPLC analysis reveales heteroduplex formation (double peak) in a PCR amplicon of individual EKV3-3 (pedigree in
middle panel), which is not present in amplicons of the una¡ected individual EKV3-11 (single peak, lower panel). (B) Generalized hyperkeratosis with white,
attached scale, hypertrichosis, and ridging over the knees with few areas of erythema in individual EKV3-13.
606 RICHARD ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 4. Mutations F137L in EKV4 and EKV11. (A), (E) Sequence chromatograms illustrate T-to-C substitution in EKV4 (panel A) and C-to-A sub-
stitution in EKV11 (panel E), each of which resides in codon 137 of GJB4 and replaces phenylalanine with leucine (top panels). The presence of transition
409T/C is indicated by a second peak in the dHPLC pro¢le of proband EKV4-3 (A, lower panel). The transversion 411T/A induces a new recognition
sequence for MseI, thus creating upon digestion two new DNA bands of 520 bp and 67 bp (not shown) in the mutant allele (E, lower panel). M, 100 bp
marker; C, control; U, undigested control; lane numbers correspond to individuals in the pedigree. (B) Figurate outlined, brownish hyperkeratotic plaques
with erythematous areas on the abdomen of individual EKV11-6. (C), (D) Acral super¢cial peeling of the stratum corneum of individuals EKV4-3 and
EKV4-6. (F), (G) Symmetrical, sharply demarcated, hyperkeratotic plaques on the legs and buttocks of a 2-y-old boy (EKV11-3). Note the circinate
erythema with prominent borders.
Table IV. GJB4 sequence variants of unknown biologic relevance and polymorphisms in una¡ected controls
Nucleotide change Codon Connexin domain Allelic frequency (%) Reference
154delGTCT PTTþ 54 E1 3.3 This study
4.5 Lopez-Bigas et al (2002)
307C/T R103C CL 0.8 Lopez-Bigas et al (2002)
369G/A K123K CL 0.01 This study
371G/A R124Q CL 0.005 This study
0.8 Lopez-Bigas et al (2002)
478C/T R160C E2 0.4 Lopez-Bigas et al (2002)
507C/G C169W E2 0.01 This study
0.4 Lopez-Bigas et al (2002)
611A/C E204A M4 N.D. This study
0.4 Lopez-Bigas et al (2002)
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reported in EKV (¢ve out of 13) involve one of two conserved
phenylalanines in M3 or in M4, suggesting a common pathome-
chanism (Wilgoss et al, 1999; Macari et al, 2000; Richard et al, 2000).
Comparisons of channel kinetics of connexins with a di¡erent
number of phenylalanines in M3 suggested that a loss of a pheny-
lalanine residue might result in faster closure of gap junction chan-
nels, which could possibly alter Cx31/Cx30.3 mediated intercellular
communication (Macari et al, 2000). It remains di⁄cult to predict
how the other mutations interfere with connexin structure and
proper topogenic assembly of connexon hemichannels as their
three-dimensional atomic structure has not been completely
solved. In general, we speculate that pathogenic defects of Cx31
and Cx30.3 exert a dominant negative e¡ect on the wild-type al-
leles, as has been demonstrated in vitro for dominant mutations in
Cx26 (Richard et al, 1998b;White et al, 1998; Rouan et al, 2001) and
Cx50 (Pal et al, 1999), and potentially on the function of selected
other connexin species (Rouan et al, 2001; M. Falk, personal com-
munication). Alternatively, survival of cells expressing mutant con-
nexins might be impaired (Di et al, 2002; Diestel et al, 2002). Such
mechanisms could explain why mutations in Cx30.3 or Cx31 can-
not be fully compensated by other epidermal connexins in vivo and
therefore result in a disease phenotype.
Defying our e¡orts, a group of seven EKV families had no
detectable pathogenic mutations in either GJB3 or GJB4, which,
together with a recently reported case (Ishida-Yamamoto et al,
2000), amounts to about one-third of all families tested. In our
cohort, no speci¢c clinical characteristics could be identi¢ed that
would help to recognize these patients based on clinical grounds.
These families could harbor small nucleotide changes in the ¢rst,
noncoding exons or regulatory gene regions, although such mu-
tations were rarely described in other connexin disorders (The
Connexin-Deafness Homepage). Another possibility is the pre-
sence of large genomic deletions within the connexin gene clus-
ter on 1p35.1, which is supported by the recent discovery of two,
possibly identical, partial deletions of GJB6 in autosomal recessive
nonsyndromic hearing loss (DFNB1) (Lerer et al, 2001; del Castil-
lo et al, 2002). These GJB6 deletions, one spanning 342 kb, were
found to be a frequent cause of hearing loss in trans with another
recessive mutation in GJB2 or GJB6 (del Castillo et al, 2002).
Finally, mutations in yet another disease gene might be impli-
cated in the pathogenesis of EKV.
Though not unusual for connexin genes, we identi¢ed a rela-
tively large number (¢ve) of nucleotide variants in the coding se-
quence of GJB4.The high allelic frequency of deletion 154del4 in
our control group (3.3%) corresponds well with data obtained in
a cohort of 243 hearing-impaired individuals (4.1%) as well as 69
normal controls (4.5%) from Spain (Lopez-Bigas et al, 2002). One
individual who was homozygous for this null allele had early on-
set hearing loss, but 154del4 did not cosegregate with hearing loss
in several other families. None of the carriers of 154del4 in either
population group had a cutaneous phenotype, suggesting that it
is probably a sequence polymorphism and that the absence of
Cx30.3 in the skin might be compensated by other connexins.
Neither study provided evidence that the deletion variant occurs
in a GJB4 pseudogene, though this possibility has not been com-
pletely excluded. We also identi¢ed three heterozygous amino
acid substitutions (R124Q, C169W, and E204A) in control indivi-
duals without skin ¢ndings, whereas Lopez-Bigas et al (2002) de-
tected these variants exclusively in small families or sporadic cases
with hearing loss but not in control individuals of normal hear-
ing (Table IV). No homozygous carrier of either variant has been
identi¢ed to date. Nonetheless, most observed sequence variants
reside within highly conserved protein domains, and, in particu-
lar, replacement of Cys169 can be expected to be detrimental to
the structural stability of the extracellular portion of Cx30.3 con-
nexons and to their ability to form complete gap junction chan-
nels (Foote et al, 1998). Considering our ¢ndings and disputes
over the biologic relevance of amino acid replacements in other
connexin genes, such as M34T in GJB2 and R32W in GJB3
(Kelsell et al, 2001; Lopez-Bigas et al, 2001; Di et al, 2002; Rouan
et al, in press), it will be necessary to carefully investigate by func-
tional assays whether these variants represent nonconsequential
polymorphisms or recessive mutations.
Figure 5. A common frameshift polymorphism of GJB4. (A) Se-
quencing analysis reveals a heterozygous deletion of 4 bp (154del4) result-
ing in frameshift in a control individual without a cutaneous phenotype
(left) compared to the wild-type sequence (right). (B) The size di¡erence be-
tween the mutant (top) and wild-type (bottom) allele is easily detectable by
HPLC under nondenaturing conditions (501C).
Figure 6. Schematic representation of connexin Cx31 and Cx30.3
polypeptides depicting the predicted structural motifs and location
of pathogenic mutations in the corresponding genes GJB3 (blue)
and GJB4 (red) in EKV. NT, cytoplasmic amino-terminus; M1^M4,
transmembrane domains; E1, E2, extracellular domains; CL, cytoplasmic
loop; CT, cytoplasmic carboxy-terminus. Domains depicted as black lines
are evolutionary conserved, whereas gray lines indicate variable protein do-
mains. Heterozygous dominant mutations in GJB4 (Cx30.3) are shown as
¢lled red circles, whereas mutations in GJB3 (Cx31) are depicted as blue
¢lled circles (Richard, 2001; Richard et al, 1998a; 2000;Wilgoss et al, 1999;
Macari et al, 2000).The asterisk and shaded background annotate a recessive
mutation (Gottfried et al, 2002).
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Correlating our molecular ¢ndings with clinical data disclosed
interesting genotypephenotype correlations. (i) Despite the ge-
netic heterogeneity of EKV, the clinical expression of GJB4 mu-
tations was similar to those in GJB3. With one exception, we
found that all patients showed either coexistence of localized-
symmetric or generalized hyperkeratosis and transient, variable
erythematous patches, or, if the latter component was missing,
they had a prior history of transient erythema (Table I). (ii)
Compared to the severe, generalized hyperkeratosis documented
in patients heterozygous for mutations G12D and F137L in GJB3
(Richard, 2001), the corresponding mutations in GJB4 appeared
to be associated with a milder, localized involvement (Table I).
Another GJB4 mutation (F189Y), however, did not follow this
trend, illustrating the need for continued investigations in a larger
cohort of EKV patients. (iii) Independent of the segregating mu-
tation in GJB4 (Table I) or GJB3 (Richard, 2001), severity and
dominating features of disease strikingly varied within families
(i.e., EKV2 or EKV3) but also during an individual’s course of
disease. In young children, the erythematous component usually
prevailed (Figs 2B, E, 4F, G), whereas hyperkeratosis was the
dominant or sole feature in adults (Figs 1B, 2C).We also identi-
¢ed a person (EKV2-2) without obvious cutaneous ¢ndings
although harboring mutation T85P, but characteristic disease-as-
sociated erythema could be induced by cold exposure. Collec-
tively, these data illustrate the marked, in part age-dependent,
clinical variability of EKV that makes genotypephenotype cor-
relations di⁄cult, and suggest the in£uence of other, yet to be
identi¢ed, genetic and environmental factors modifying the clin-
ical phenotype in EKV. (iv) Taking into account the clinical
variability of EKV, the only appreciable phenotypic di¡erence
between individuals harboring mutations in GJB3 versus GJB4
was the occurrence of rapidly changing, targetoid, or garland-like
erythema with circinate borders in patients with faulty Cx30.3.
Such lesions resembling erythema gyratum repens were ¢rst
described in a Kurdish EKV family segregating with the GJB4
mutation F137L (Macari et al, 2000).We observed this feature in
four children and one adolescent of two unrelated EKV families
(EKV2 and EKV11) harboring mutationsT85P and F137L, respec-
tively (Figs 2B, E, 4F, G), whereas it was absent in all reported
families with GJB3mutations (Wilgoss et al, 1999; Richard, 2001).
These data suggest that circinate or gyrate erythema may be a
speci¢c manifestation of GJB4mutations, although the molecular
and biologic mechanisms leading to localized capillary dilatation
in EKV are elusive.
In summary, we have elucidated the molecular basis of EKV in
six unrelated families and identi¢ed ¢ve new pathogenic mis-
sense mutations and a series of common sequence variants in
GJB4. Our results establish the genetic heterogeneity of EKV
and demonstrate the highly variable intrafamilial expression of
GJB4 mutations, which may include short-lasting erythematous
patches with circinate or gyrate borders.
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